CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.

Autres langues China Resources Double-Crane Pharmaceutical Co.,Ltd.

Actions

600062

CNE000000Q94

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
17,42 ^CNY	-0,91 %		-4,70 %	-6,34 %

03/07	Une unité de Double-Crane Pharmaceutical reçoit le feu vert de la Chine pour un médicament contre la grippe	MT
28/06	CR Double-Crane Pharmaceutical enregistre des antibiotiques et des médicaments contre les ulcères en Chine	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Double-Crane Pharmaceutical Unit Gets China Nod for Influenza Drug	03/07
CR Double-Crane Pharmaceutical Registers Antibiotic, Ulcer Medications in China	28/06
CR Double-Crane Pharmaceutical Gets Certificate to Market Low-Calcium Dialysis Solution	14/06
CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection	27/05
CR Double-Crane Pharmaceutical's Unit Gets Nod to Market Schizophrenia Drug	23/05
CR Double-Crane Pharmaceutical's Unit Gets Nod for Lidocaine Hydrochloride Injection	08/05
CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2%	26/04
CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication	26/04
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
CR Double-Crane Pharmaceutical Gets Nod to Trial Semaglutide Injection	16/04
CR Double-Crane Pharma Unit Receives Approval for Epilepsy Drug	26/03
CR Double-Crane Pharma's 2023 Profit Jumps 13%, Operating Income Climbs 6%	22/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. Proposes Cash Dividend	21/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
CR Double-crane Pharmaceutical Gets Nod to Market Doxazosin Mesylate Tablets	12/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire China Resources Zizhu Pharmaceutical Co., Ltd. from Beijing Pharmaceutical Group Co., Ltd. for CNY3.1 billion.	26/02
CR Double-Crane Pharma Gets Nod for Apixaban Tablets; Unit's Clozapine Orally Disintegrating Tablets Gets Greenlight for Proposed Amendments	21/02
CR Double-Crane Pharma's Unit Gets Nod to Market Lithium Carbonate Drug Ingredient	08/02
CR Double-Crane Pharmaceutical's Unit Gets Nod to Raise Strength of Viagra Drug	31/01
China Includes CR Double-Crane Pharmaceutical's Two Drugs in List of Insurance-Backed Drugs	14/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues China Resources Double-Crane Pharmaceutical Co.,Ltd.

Actions

600062

CNE000000Q94

Autres langues

Filtres